Skip to content

AbCellera Biologics Inc. ABCL Intangible Amortization

Intangible Amortization at other companies

Zymeworks logo
ZymeworksZYME
$176K-89.1%
ADMA Biologics logo
ADMA BiologicsADMA
$55K+120%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$5.72M+4.0%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$600K
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$419K0.0%

Other financials

Income statement

See full
Revenue$8.3M+96.3%
Operating income-$57.5M+8.2%
Net income-$43.2M+5.4%
EPS (diluted)-$0.14+6.7%

Balance sheet

See full
Cash & equivalents$102.1M-44.6%
Total debt$140.2M+107%
Total equity$938.1M-8.3%
Total assets$1.3B-2.8%

Cash flow

See full
Operating cash flow-$33.5M-190%
CapEx$3.8M-64.0%
Free cash flow-$37.4M-68.3%

Valuation

See full
Market cap$1.84B+59.2%

Profitability

See full
Operating margin-267.6%-120pp
Net margin-181.7%-77.9pp
FCF margin-238.9%-90.9pp

Returns & leverage

See full
Return on equity-14.7%-0.8pp
Debt / equity0.1×+0.1×
Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s intangible amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbCellera Biologics Inc.'s intangible amortization?
AbCellera Biologics Inc. (ABCL) reported intangible amortization of $920K in Q1 2026.
How has AbCellera Biologics Inc.'s intangible amortization changed year-over-year?
AbCellera Biologics Inc.'s intangible amortization decreased by 0.2% year-over-year, from $922K to $920K.
What does intangible amortization mean?
Non-cash amortization of intangible assets (patents, customer relationships, technology) acquired through M&A or purchases.